Dr. Clayton successfully cultured lice on captive birds, such as common pigeons, for basic research purposes.
After years of development and experimentation, Dr. Clayton’s lab created a custom-engineered prototype they dubbed the “LouseBuster.” The results of this work were published in 2006 in the journal Pediatrics. This paper revealed the success of the LouseBuster device for killing head lice and their eggs. An accompanying press release by the University of Utah got attention worldwide, leading to international interest in this device, and the critical need for it.
That 2006 study as well as a 2011 published clinical study demonstrated the safety and efficacy of the AirAllé® device and treatment (see published data in the peer-reviewed Pediatrics and Journal of Medical Entomology). Subsequently, the FDA-cleared the AirAllé® for head lice treatments. Thousands of successful lice treatments are being performed each month with the AirAllé® device.
Larada Sciences was formed in 2006 to take this innovative technology to market. In 2014 Larada Sciences created the Lice Clinics of America brand.